Commercial applications
Commercial applications may include authorized diagnostic evaluation, study planning and biomarker or therapy development.
Molecular and disease cohorts
Develop a brief that connects assay, specimen, diagnosis and clinical timeline. This category spans molecular diagnostics, digital pathology, disease cohorts and documented treatment outcomes.
Dataset scope
Potential deliverables include VCF or panel tables, whole-slide image formats, structured clinical tables and manifests describing tissue handling and specimen linkage.
Commercial applications may include authorized diagnostic evaluation, study planning and biomarker or therapy development.
Matched cohorts can support molecular characterization or outcome studies. Define index treatment, response criteria, censoring and minimum observation requirements before comparing datasets.
Due diligence
Assess sequencing depth, panel version, tissue preservation, scanner settings, slide coverage and consistency of staging. Document exclusions and missing follow-up.
Clarify rights for each data modality and linked outcome. Define permitted analyses, publication, derived outputs and access controls for sensitive data.
Genetic information can remain sensitive after direct identifiers are removed. Review consent scope, institutional permissions, linkage risk and restrictions on sharing or cross-border processing.
Specify disease and subtype, assay or slide modality, cohort volume, follow-up and what specimen-level linkage is required.
See the sourcing processCommon questions
Pairing depends on source linkage, specimen identity and authorization for combined use. Request a linkage inventory and completeness figures before agreeing scope.
Specify line of treatment, outcome definition, timing, censoring and source of verification. State which variables must be present for each record.
Share business contact details and non-sensitive aggregate information. Keep records, credentials and raw datasets out of this form.
Online inquiry submission is temporarily unavailable. Use the email shown on the Contact page.
Share business contact details and non-sensitive aggregate information. Keep records, credentials and raw datasets out of this form.
Online inquiry submission is temporarily unavailable. Use the email shown on the Contact page.